http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005521699-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate | 2003-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2005521699-A |
| titleOfInvention | Dipyridodiazepinones as reverse transcriptase inhibitors |
| abstract | Useful as inhibitors of HIV reverse transcriptase, Formula I wherein R 2 is H, halogen, (C 1-4 ) alkyl, O (C 1-4 ) alkyl, NH (C 1-4 alkyl) or R 4 is H or CH 3 ; R 5 is H or CH 3 ; R 12 is H, halogen, (C 1-4 ) alkyl, N (C 1-4 alkyl) 2 ; CF 3 or NO 2 ; R 13 is H, (C 1-4 ) alkyl, halogen, OH or NH 2 , provided that R 12 and R 13 are not both H; R 14 is COOR 14a, R 14a is H or (C 1-6) alkyl; or R 14 is (C 2-4) alkenyl -COOR 14a, R 14a are as defined above; or R 14 is (C 1-4 ) alkylCOOR 14a , R 14a is as defined above) or a salt or prodrug thereof. |
| priorityDate | 2002-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 207.